The new standard of COVID-19 solutions

Claim My Business
Min Investment
Las Vegas, NV
Offering Date
December 16, 2022
Expected Close Date
February 15, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

CovInnovations™ is a life sciences company primarily focused on discovering and developing groundbreaking technologies that assess, diagnose, and treat COVID-19. With that, we have developed a potential cure for hospitalized patients with severe COVID-19 in need of oxygen supplementation - helping people bring back the immune response they need to fight the virus. Our company is in the R&D and prototyping stages and we intend to launch with this campaign. The Company is in the pre-revenue stage of development.

Key Deal Facts

We believe our clinical solution, COVI-001, has significant clinical efficacy, patent protection and a first-to-market position - satisfying clear unmet needs for COVID-19 patients and their healthcare providers.

There are more than 150K hospitalized patients with severe COVID-19 across the world daily (source). The Global COVID-19 Therapeutics Market is worth $14.6 Billion, and is expected to reach $25.6 Billion in 2030 (source).

Board and leadership team includes pharmaceutical executives with over 30 years of drug development, corporate and commercial leadership experience.
Amount Raised : $4,089
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Research Reports

No reports have been submitted

Become a Reporter